From the Desk of Evan Yu: “Clinical Trial Updates of Single-Agent PARP Inhibitor Use in Homologous Recombination Deficient Prostate Cancer Populations.” – UroToday

From the Desk of Evan Yu: “Clinical Trial Updates of Single-Agent PARP Inhibitor Use in Homologous Recombination Deficient Prostate Cancer Populations.”  UroToday

Published 07 January 2019; When this monthly Clinical Trials Portal first started at the beginning of 2017, I focused on what I thought to be one of the newest, …

Source: Genome Sequencing